FDA Demands Stronger Warnings For TNF-Blockers
The U.S. Food and Drug Administration said Thursday that the manufacturers of four drugs known as tumor necrosis factor alpha blockers must strengthen existing safety warnings for the medications in the...To view the full article, register now.
Already a subscriber? Click here to view full article